|
 |
Ronald B. Smeltz, Ph.D.
Assistant Professor
Phone: (804) 828-8085
Dept. Fax: (804) 828-9946
e-mail:
rbsmeltz@vcu.edu
Address:
Department of Microbiology & Immunology
Virginia Commonwealth University
Molecular Medicine Research Building, Room 4044
Richmond, VA 23298-0678
Professional Experience
-
B.S., 1993,
The University of Akron
-
M.S., 1995,
The University of Akron
-
Ph.D., 1999,
Wayne State University
-
Postdoctoral
Fellow, 1999-2002, National Institutes of Health
-
Research
Scientist, 2002-2005, Aventis Pharmaceuticals
Recent
Awards:
2009
American Association of Immunologists (AAI) Junior Faculty Award
2007
American Association of Immunologists (AAI) Junior Faculty Award
Research Interests:
T
cells (including CD4+ T helper cells and CD8+
cytotoxic T cells), cytokines (including IFN-g,
IL-17), transcription factors (including T-bet), T cell immunity to
infection.
Research Summary:
T cells are critical to the body’s immune defense against
infection, especially in the control of intracellular pathogens such as
Trypanosoma cruzi
(T.
cruzi),
the etiologic agent of Chagas disease. Without T cells, immunodeficient
hosts rapidly succumb to
T. cruzi
infection. Two primary means by which T cells control/eliminate
intracellular pathogens are via secretion of cytokines (ie. gamma
interferon, or IFN-g) and cytotoxicity (ie. killing). Many anti-microbial T
cell functions are regulated by T-bet, a T-box family transcription factor
expressed primarily in T cells. Defects and polymorphisms in T-bet
expression are linked to an increased susceptibility to intracellular
infections including Mycobacterium
(causative agent of tuberculosis), Salmonella, and HSV. We recently
reported that T-bet is required for host protection against
T.
cruzi1
Using
T. cruzi
infection as our model, our laboratory's mission is to understand the
molecular basis of T cell responses to infection. Information gained
from such studies will improve future efforts aimed at enhancing T cell
immunity to infections through vaccination.
Specific projects:
1.
T-bet-dependent regulation of CD4+ Th17 cell differentiation
2.
Transcriptional regulation of CD8+ T cell responses to infection
My laboratory uses state-of-the-art techniques such as MHC
tetramers, retroviral-mediated gene delivery, flow cytometry, CFSE dilution
and use of congenic T cells for long-term tracking of antigen-specific T
cells in vivo, confocal microscopy, and in situ analysis. Interested
students should contact Dr. Smeltz to schedule a laboratory rotation
Laboratory members
(above): Ronald Smeltz (left), Siqi Guo (center), and Dustin Cobb
(right)

Movie
(above):
extensive parasitemia in Rag-2-deficient host, which has no T cells, on day
21 post-infection with
T.
cruzi. High
numbers of
T
cruzi
trypomastigotes can be seen. Courtesy of Ana Maria Lara and laboratory of
Dr. Gregory Buck.

Images:
Confocal analysis and immunofluorescent detection of T. cruzi
amastigotes in skeletal muscle using serum from hosts chronically infected
with T. cruzi (Left: 100x magnification, Middle: 100x DIC image,
Right: 10x magnification. Blue = DAPI, Green = anti-mouse IgG FITC).
Selected
Publications:
1. Cobb, DA,
Guo, S., Lara, AM, Manque, P, Buck, G, and Smeltz, R.B.
T-bet-dependent regulation of CD8+ T cell expansion during
experimental Trypanosoma cruzi infection. Immunology, 2009 (in
press).
2. Guo, S.,
Cobb, DA, and Smeltz, R.B. T-bet inhibits the in vivo differentiation
of parasite-specific CD4+ Th17 cells in a T cell-intrinsic
manner. The Journal of Immunology
182:6179–6186, 2009.
3. Smeltz, R.B.
Profound enhancement of the IL-12/IL-18 pathway of IFN-g secretion in human
CD8+ memory T cell subsets via IL-15. The Journal of Immunology
178:4786-4792, 2007.
4.
Smeltz, R.B., Chen, J., and E.M. Shevach. TGF-b1 enhances
the IFN-g-dependent, IL-12/STAT-4-independent pathway of Th1 cell
differentiation. Immunology 114(4):484-92,
2005.
(Additional publications can be found on Pub Med) |